Benzodiazepines may reduce the effectiveness of ketamine in the treatment of depression
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, there are significant overlaps in the cognitive dysfunction pattern between chronic ketamine and methamphetamine users.182–188”
From Ketamine as an antidepressant: Overview of its mechanisms of action and potential predictive biomarkers (2020) · cites this paper as [183]
In the citing paper
“Another consideration supporting cognition as a key driver of ketamine response could be the potential decreased efficacy of ketamine clinically when benzodiazepines (which are known to impair cognitive processes) are co-administered.182–184”
From Ketamine as an antidepressant: Overview of its mechanisms of action and potential predictive biomarkers (2020) · cites this paper as [183]
Citations
Cites
Naughton, M., Clarke, G., O′Leary, O. F., Cryan, J. F., & Dinan, T. G. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.11.014 · Cited by 190
Eintrei, C., Sokoloff, L., & Smith, C. B. (1999) · British Journal of Anaesthesia · doi:10.1093/bja/82.4.596 · Cited by 49
Irifune, M., Fukuda, T., Nomoto, M., Sato, T., Kamata, Y., Nishikawa, T., MIETANI, W., Yokoyama, K., Sugiyama, K., & Kawahara, M. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00510-6 · Cited by 47
Cited by
McIntyre, R. S., Rosenblat, J. D., Nemeroff, C. B., Sanacora, G., Murrough, J. W., Berk, M., Brietzke, E., Dodd, S., Gorwood, P., Ho, R., et al. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20081251 · Cited by 731
Matveychuk, D., Thomas, R. K., Swainson, J., Khullar, A., MacKay, M.-A., Baker, G. B., & Dursun, S. M. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320916657 · Cited by 209
Ketamine: Mechanisms and Relevance to Treatment of Depression
Kim, J., Suzuki, K., Kavalali, E. T., & Monteggia, L. M. (2023) · Annual Review of Medicine · doi:10.1146/annurev-med-051322-120608 · Cited by 147
Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder
Jaso, B. A., Niciu, M. J., Iadarola, N. D., Lally, N., Richards, E. M., Park, M., Ballard, E. D., Nugent, A. C., Machado-Vieira, R., & Zarate, C. A. (2017) · Current Neuropharmacology · doi:10.2174/1570159x14666160321123221 · Cited by 98
THERAPEUTIC MECHANISMS OF KETAMINE
Mihaljević, S., Pavlović, M., Reine, K., & Čačić, M. (2020) · Psychiatria Danubina · doi:10.24869/psyd.2020.325 · Cited by 94
Metadata
- Authors
- Ford, N., Ludbrook, G., & Galletly, C.
- Affiliations
- The University of Adelaide (AU)
- Corresponding author
- Galletly, Cherrie
- Venue
- Australian & New Zealand Journal of Psychiatry
- Publisher
- SAGE Publications
- Published
- 2015-06-09
- Volume
- 49
- Issue
- 12
- Pages
- 1227-1227
- ISSN
- 0004-8674 (ISSN-L)
- 1440-1614
- OpenAlex
- W2272012343
- Cited by
- 23
- References
- 3
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 2 · 2021: 7 · 2020: 4 · 2018: 1 · 2017: 3 · 2016: 2
- FWCI
- 1.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Australian & New Zealand Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Keywords
- benzodiazepines, ketamine, depression, antidepressant efficacy, drug interactions, treatment-resistant depression
- MeSH terms
- Quetiapine Fumarate, Antidepressive Agents, Benzodiazepines, Bipolar Disorder, Drug Interactions, Drug Therapy, Combination, Fluoxetine, Humans, Ketamine, Lorazepam, Middle Aged, Antipsychotic Agents, Lithium Compounds, Antimanic Agents, Depressive Disorder, Treatment-Resistant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Benzodiazepines may reduce the effectiveness of ketamine in the treatment of depression. https://app.cochat.ai/papers/10.1177/0004867415590631
- The paper
- Ford, N., Ludbrook, G., & Galletly, C. (2015). Benzodiazepines may reduce the effectiveness of ketamine in the treatment of depression. Australian & New Zealand Journal of Psychiatry. https://doi.org/10.1177/0004867415590631
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.